Integra Adds Depth to Neurosurgery Unit with Rebound Deal
Integra LifeSciences is gaining a new minimally invasive platform for neurosurgery through its acquisition of Rebound Therapeutics. The Plainsboro, NJ-based company did not disclose the financial terms of the deal.
Rebound Therapeutics develops single-use medical devices that enable minimally invasive access, using optics and illumination, for visualization, diagnostic, and therapeutic use in neurosurgery.
âThe acquisition of Rebound Therapeutics reflects Integraâs ongoing commitment to developing innovative products to address unmet needs in neurosurgery,â Dan Reuvers, corporate VP and president of Integra LifeSciencesâ Codman Specialty Surgical division said in a release. âReboundâs MIS technological platform is a natural addition to our portfolio of neurosurgical products and will expand our therapeutic-focused offerings. We are eager to further develop Reboundâs cutting-edge MIS technologies to help surgeons improve the standard of care for neurosurgery patients.â
Integra dipping its feet into the M&A waters shouldnât come as a surprise. During a July earnings call, Glenn Coleman, Corporate VP, and COO, of Integra indicated that acquisitions could be on the horizon.
âWe maintain a strong and flexible balance sheet with cash and cash equivalents of $176 million and capacity on our revolver of...
Source: MDDI - Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news